| Literature DB >> 19291727 |
Joshua J Field1, Robert C Strunk, Jessica E Knight-Perry, Morey A Blinder, R Reid Townsend, Michael R DeBaun.
Abstract
Baseline level of the cysteinyl leukotriene (CysLT), leukotriene E4 (LTE4), is associated with an increased pain rate in children and adults with sickle cell disease (SCD). To provide additional evidence for a role of CysLTs in the pathogenesis of vaso-occlusion, we tested the hypothesis that LTE4 levels will increase within an individual during painful episodes compared to baseline. In a cohort of 19 children and adults with SCD, median LTE4 levels increased from 82.36 pg/mg creatinine at baseline to 162.81 pg/mg creatinine during a painful episode (P < 0.001). These data further support a contribution of CysLTs to the process of vaso-occlusion. Copyright 2009 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19291727 DOI: 10.1002/ajh.21370
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047